Systematic review and meta-analysis of traditional Chinese medicine in the treatment of constipation-predominant irritable bowel syndrome.

<h4>Aim</h4>This meta-analysis analyzed the efficacy and safety of traditional Chinese medicine (TCM) for the treatment of irritable bowel syndrome with constipation (IBS-C).<h4>Methods</h4>We searched seven electronic databases for randomized controlled trials investigating...

Full description

Saved in:
Bibliographic Details
Main Authors: Dan-Yan Li, Yun-Kai Dai, Yun-Zhan Zhang, Meng-Xin Huang, Ru-Liu Li, Jia Ou-Yang, Wei-Jing Chen, Ling Hu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0189491
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849682933983477760
author Dan-Yan Li
Yun-Kai Dai
Yun-Zhan Zhang
Meng-Xin Huang
Ru-Liu Li
Jia Ou-Yang
Wei-Jing Chen
Ling Hu
author_facet Dan-Yan Li
Yun-Kai Dai
Yun-Zhan Zhang
Meng-Xin Huang
Ru-Liu Li
Jia Ou-Yang
Wei-Jing Chen
Ling Hu
author_sort Dan-Yan Li
collection DOAJ
description <h4>Aim</h4>This meta-analysis analyzed the efficacy and safety of traditional Chinese medicine (TCM) for the treatment of irritable bowel syndrome with constipation (IBS-C).<h4>Methods</h4>We searched seven electronic databases for randomized controlled trials investigating the efficacy of TCM in the treatment of IBS-C. The search period was from inception to June 1, 2017. Eligible RCTs compared TCM with cisapride and mosapride. Article quality was evaluated with the Cochrane Risk Bias Tool in the Cochrane Handbook by two independent reviewers. Begg's test was performed to evaluate publication bias. Review Manager 5.3 and Stata 12.0 were used for analyses.<h4>Results</h4>Eleven eligible studies comprising a total of 906 participants were identified. In the primary outcome, TCM showed significant improvement in overall clinical efficacy compared with cisapride and mosapride (odds ratio [OR] = 4.00; 95% confidence interval [CI]: 2.74,5.84; P < 0.00001). In terms of secondary outcomes, TCM significantly alleviated abdominal pain (OR = 5.69; 95% CI: 2.35, 13.78; P = 0.0001), defecation frequency (OR = 4.38; 95% CI: 1.93, 9.93. P = 0.0004), and stool form (OR = 4.96; 95% CI: 2.11, 11.65; P = 0.0002) in the treatment group as compared to the control group. A lower recurrence rate was associated with TCM as compared to cisapride and mosapride (OR = 0.15; 95% CI: 0.08, 0.27; P < 0.00001). No adverse effects were observed during TCM treatment.<h4>Conclusions</h4>TCM showed greater improvement in terms of clinical efficacy in the treatment of IBS-C than cisapride and mosapride, although it was not possible to draw a definitive conclusion due to the small sample size, high risk, and low quality of the studies. Large multi-center and long-term high-quality randomized control trials are needed.
format Article
id doaj-art-31d8f97c8b434521885dcfb91586acf6
institution DOAJ
issn 1932-6203
language English
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-31d8f97c8b434521885dcfb91586acf62025-08-20T03:24:02ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-011212e018949110.1371/journal.pone.0189491Systematic review and meta-analysis of traditional Chinese medicine in the treatment of constipation-predominant irritable bowel syndrome.Dan-Yan LiYun-Kai DaiYun-Zhan ZhangMeng-Xin HuangRu-Liu LiJia Ou-YangWei-Jing ChenLing Hu<h4>Aim</h4>This meta-analysis analyzed the efficacy and safety of traditional Chinese medicine (TCM) for the treatment of irritable bowel syndrome with constipation (IBS-C).<h4>Methods</h4>We searched seven electronic databases for randomized controlled trials investigating the efficacy of TCM in the treatment of IBS-C. The search period was from inception to June 1, 2017. Eligible RCTs compared TCM with cisapride and mosapride. Article quality was evaluated with the Cochrane Risk Bias Tool in the Cochrane Handbook by two independent reviewers. Begg's test was performed to evaluate publication bias. Review Manager 5.3 and Stata 12.0 were used for analyses.<h4>Results</h4>Eleven eligible studies comprising a total of 906 participants were identified. In the primary outcome, TCM showed significant improvement in overall clinical efficacy compared with cisapride and mosapride (odds ratio [OR] = 4.00; 95% confidence interval [CI]: 2.74,5.84; P < 0.00001). In terms of secondary outcomes, TCM significantly alleviated abdominal pain (OR = 5.69; 95% CI: 2.35, 13.78; P = 0.0001), defecation frequency (OR = 4.38; 95% CI: 1.93, 9.93. P = 0.0004), and stool form (OR = 4.96; 95% CI: 2.11, 11.65; P = 0.0002) in the treatment group as compared to the control group. A lower recurrence rate was associated with TCM as compared to cisapride and mosapride (OR = 0.15; 95% CI: 0.08, 0.27; P < 0.00001). No adverse effects were observed during TCM treatment.<h4>Conclusions</h4>TCM showed greater improvement in terms of clinical efficacy in the treatment of IBS-C than cisapride and mosapride, although it was not possible to draw a definitive conclusion due to the small sample size, high risk, and low quality of the studies. Large multi-center and long-term high-quality randomized control trials are needed.https://doi.org/10.1371/journal.pone.0189491
spellingShingle Dan-Yan Li
Yun-Kai Dai
Yun-Zhan Zhang
Meng-Xin Huang
Ru-Liu Li
Jia Ou-Yang
Wei-Jing Chen
Ling Hu
Systematic review and meta-analysis of traditional Chinese medicine in the treatment of constipation-predominant irritable bowel syndrome.
PLoS ONE
title Systematic review and meta-analysis of traditional Chinese medicine in the treatment of constipation-predominant irritable bowel syndrome.
title_full Systematic review and meta-analysis of traditional Chinese medicine in the treatment of constipation-predominant irritable bowel syndrome.
title_fullStr Systematic review and meta-analysis of traditional Chinese medicine in the treatment of constipation-predominant irritable bowel syndrome.
title_full_unstemmed Systematic review and meta-analysis of traditional Chinese medicine in the treatment of constipation-predominant irritable bowel syndrome.
title_short Systematic review and meta-analysis of traditional Chinese medicine in the treatment of constipation-predominant irritable bowel syndrome.
title_sort systematic review and meta analysis of traditional chinese medicine in the treatment of constipation predominant irritable bowel syndrome
url https://doi.org/10.1371/journal.pone.0189491
work_keys_str_mv AT danyanli systematicreviewandmetaanalysisoftraditionalchinesemedicineinthetreatmentofconstipationpredominantirritablebowelsyndrome
AT yunkaidai systematicreviewandmetaanalysisoftraditionalchinesemedicineinthetreatmentofconstipationpredominantirritablebowelsyndrome
AT yunzhanzhang systematicreviewandmetaanalysisoftraditionalchinesemedicineinthetreatmentofconstipationpredominantirritablebowelsyndrome
AT mengxinhuang systematicreviewandmetaanalysisoftraditionalchinesemedicineinthetreatmentofconstipationpredominantirritablebowelsyndrome
AT ruliuli systematicreviewandmetaanalysisoftraditionalchinesemedicineinthetreatmentofconstipationpredominantirritablebowelsyndrome
AT jiaouyang systematicreviewandmetaanalysisoftraditionalchinesemedicineinthetreatmentofconstipationpredominantirritablebowelsyndrome
AT weijingchen systematicreviewandmetaanalysisoftraditionalchinesemedicineinthetreatmentofconstipationpredominantirritablebowelsyndrome
AT linghu systematicreviewandmetaanalysisoftraditionalchinesemedicineinthetreatmentofconstipationpredominantirritablebowelsyndrome